Taiwan Dollar Falls Rapidly Again, Reinforcing Intervention Talk
The currency plunged more than 2% against the greenback to as weak as 29.895, according to data compiled by Bloomberg. The trading pattern — a sudden slump towards the end of the session — resembled a move seen last week that stoked bets the central bank may have sold the local dollar after it jumped to a three-year high.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
South Korea to step up US trade talks before tariffs kick in on August 1
By Jack Kim SEOUL (Reuters) -South Korea said it planned to intensify trade talks with the United States and considers U.S. President Donald Trump's plan for a 25% tariff from August 1 as effectively extending a grace period on implementing reciprocal tariffs. Trump said on Monday he would impose the tariff on goods from South Korea starting on August 1, posting a letter to President Lee Jae Myung on his social media platform along with one to Japan's leader. South Korea's Industry Ministry said in a statement that the letter effectively extends a grace period on the implementation of reciprocal tariffs by the United States. "We will step up negotiations during the remaining period to reach a mutually beneficial result to quickly resolve the uncertainties from tariffs," it said. "We also plan to use it as an opportunity to improve domestic systems and regulations to resolve the trade deficit that is a major interest of the United States and advance key industries through a manufacturing renaissance partnership between the two countries," it said. South Korea's top trade envoy and presidential security adviser have traveled to the United States in recent days for trade and defence talks as Asia's fourth largest economy races to seek an exemption from Trump's threatened tariffs. The Industry Ministry in the statement conceded it did not have enough time after the start of a new administration in South Korea to reach an agreement with the United States on all issues despite intense negotiations. South Korean President Lee took office on June 4 after winning a snap election after his predecessor's December martial law declaration, which he said had greatly impaired the country's response to U.S. trade policy and new tariffs.
Bloomberg
an hour ago
- Bloomberg
A 36-Year-Old Beauty Mogul Is South Korea's Newest Billionaire
In a 15-second TikTok clip that has racked up millions of views, Kylie Jenner glides a sleek silver device across her face, swearing by its ability to help skin absorb serums more effectively. Dubbed the Booster Pro, the gadget's video has gone viral — and with it, the fortunes of its maker APR Corp., a once-obscure Seoul-based startup now at the center of the K-beauty boom. Behind the firm is 36-year-old Kim Byung Hoon, a tech entrepreneur-turned-beauty mogul whose company has made him South Korea's newest billionaire. His 31% stake in APR is now worth about $1.3 billion, according to the Bloomberg Billionaires Index, after the firm's shares soared 200% this year.
Yahoo
an hour ago
- Yahoo
3 Asian Stocks Estimated To Be Up To 38.1% Below Intrinsic Value
As global markets experience a mix of highs and lows, with the U.S. indices hitting record peaks and Asian markets showing varied performance, investors are increasingly focused on opportunities that may be undervalued in the current economic landscape. In this context, identifying stocks that are trading below their intrinsic value can be a prudent strategy for those looking to capitalize on potential market inefficiencies. Name Current Price Fair Value (Est) Discount (Est) Taiwan Union Technology (TPEX:6274) NT$229.00 NT$455.26 49.7% Serko (NZSE:SKO) NZ$3.14 NZ$6.27 49.9% Nanya New Material TechnologyLtd (SHSE:688519) CN¥42.98 CN¥85.50 49.7% Livero (TSE:9245) ¥1715.00 ¥3414.75 49.8% Lai Yih Footwear (TWSE:6890) NT$287.50 NT$571.27 49.7% HL Holdings (KOSE:A060980) ₩40850.00 ₩81170.42 49.7% Hibino (TSE:2469) ¥2364.00 ¥4705.08 49.8% Dive (TSE:151A) ¥933.00 ¥1858.19 49.8% Darbond Technology (SHSE:688035) CN¥39.42 CN¥78.37 49.7% cottaLTD (TSE:3359) ¥429.00 ¥854.05 49.8% Click here to see the full list of 267 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's review some notable picks from our screened stocks. Overview: Beijing Chunlizhengda Medical Instruments Co., Ltd. is a company that specializes in the production and sale of orthopedic implants and medical instruments, with a market cap of approximately HK$7.16 billion. Operations: The company's revenue primarily comes from its manufacture and trading of surgical implants, instruments, and related products, totaling approximately CN¥813.85 million. Estimated Discount To Fair Value: 35.2% Beijing Chunlizhengda Medical Instruments is trading at HK$13.24, significantly below its estimated fair value of HK$20.42, suggesting undervaluation based on discounted cash flow analysis. Despite a recent decline in profit margins from 23.4% to 15.7%, the company exhibits robust earnings growth forecasts of over 27% annually, outpacing the Hong Kong market's average growth rate. Recent share buybacks and stable dividends further underline its potential as an undervalued investment opportunity in Asia. Our earnings growth report unveils the potential for significant increases in Beijing Chunlizhengda Medical Instruments' future results. Click here and access our complete balance sheet health report to understand the dynamics of Beijing Chunlizhengda Medical Instruments. Overview: Shenzhen Noposion Crop Science Co., Ltd. engages in the research, development, production, and sale of agricultural inputs both in China and internationally, with a market cap of CN¥10.60 billion. Operations: Shenzhen Noposion Crop Science Co., Ltd. generates its revenue primarily through the research, development, production, and sale of agricultural inputs in both domestic and international markets. Estimated Discount To Fair Value: 22.8% Shenzhen Noposion Crop Science is trading at CNY 10.7, below its estimated fair value of CNY 13.85, indicating undervaluation based on discounted cash flow analysis. Despite having a high level of debt and a dividend yield not fully covered by free cash flows, the company shows strong earnings growth with net income rising to CNY 626.93 million in Q1 2025 from CNY 454.31 million a year earlier, reflecting robust profit expansion prospects in Asia. Upon reviewing our latest growth report, Shenzhen Noposion Crop Science's projected financial performance appears quite optimistic. Click here to discover the nuances of Shenzhen Noposion Crop Science with our detailed financial health report. Overview: MeHow Innovative Ltd. is a company that designs, develops, manufactures, and sells precision medical device components and products both in China and internationally, with a market cap of CN¥10.30 billion. Operations: MeHow Innovative generates its revenue from the design, development, manufacturing, and sales of precision medical device components and products across domestic and international markets. Estimated Discount To Fair Value: 38.1% MeHow Innovative is trading at CN¥18.22, significantly below its estimated fair value of CN¥29.42, highlighting potential undervaluation based on discounted cash flow analysis. Despite a recent decrease in net income to CN¥51.87 million for Q1 2025 from CN¥58.04 million a year ago, earnings grew by 36% over the past year and are forecasted to increase by 22.87% annually, outpacing China's market revenue growth projections of 12.4%. Our growth report here indicates MeHow Innovative may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in MeHow Innovative's balance sheet health report. Delve into our full catalog of 267 Undervalued Asian Stocks Based On Cash Flows here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1858 SZSE:002215 and SZSE:301363. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
